The report provides market dynamics and trends related to the global veterinary CRO market. In addition, it presents the estimations and forecast of the market. It includes revenue generated from the sales of services such as clinical trials, toxicology, and market authorization & regulatory support. For the purpose of analysis, the global veterinary CRO market is segmented on the basis of service type, animal type, indication, and region. The study estimates the revenue generated from the sale of services such as clinical trials, toxicology, market authorization & regulatory support, and others. By indication, the market is divided into oncology, infectious diseases, neurology, and others. This further provides an understanding of the use of veterinary CRO service types in the market. Moreover, the report covers revenue generated from the sales of veterinary CRO services offered in regions such as North America, Europe, Asia-Pacific and LAMEA.

从需求端来看，猪肉是我国第一大肉类生产品类，占比维持在60%以上。根据国家统计局数据，2016-2018年，猪肉产量维持在5400万吨左右，占全国肉类总产量的比重为60%以上，2019年，受非洲猪瘟疫情影响，全国猪肉产量4255万吨，同比下滑21.26% ，创近17年来最低水平，占全国肉类总产量的比重下降至55.63%。

我们认为，当下优质养殖股的核心矛盾在于成长性而非周期下行风险。在非瘟常态化背景下，猪价高位宽幅震荡或是常态，而由于行业壁垒提高，优质企业超额回报或将提升，此阶段调整正为优质养殖股配置机会。首推牧原股份；重点推荐温氏股份，傲农生物；建议关注正邦科技，新希望，唐人神，金新农。